Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference?

Area of Science:

• Clinical Pharmacy
• Pediatric Pulmonology
• Health Services Research

Background:

• Asthma is a chronic respiratory disease affecting millions of children and adolescents.
• Effective disease management is crucial for improving quality of life and reducing healthcare costs.
• Pharmaceutical care interventions aim to optimize medication use and patient outcomes.

Purpose of the Study:

• To evaluate the impact of a structured pharmaceutical care program on pediatric asthma patients.
• To assess changes in disease control, functional status, and healthcare utilization.
• To determine the effectiveness of pharmacist-led asthma management in community settings.

Main Methods:

• Randomized controlled trial involving 330 children (6-17 years) with moderate-to-severe asthma.
• Intervention group received structured pharmaceutical care from trained pharmacists for up to 1 year.
• Primary outcomes included pulmonary function (peak expiratory flow rate, spirometry); secondary outcomes were functional status and healthcare service use.

Main Results:

• The pharmaceutical care intervention demonstrated no significant improvement in pulmonary function, functional status, or quality of life.
• No differences were observed in asthma management, patient satisfaction, or use of anti-inflammatory medications.
• Healthcare utilization, including medical visits and school days missed, did not differ between intervention and usual care groups.

Conclusions:

• A structured pharmaceutical care program did not significantly impact health or healthcare use outcomes in pediatric asthma patients.
• The intervention's limited effect may be due to insufficient impact on pharmacist behavior or low compliance.
• Patient and practice-related obstacles may have hindered the intervention's success in community pharmacy settings.